A MnO2 Nanoparticle-Dotted Hydrogel Promotes Spinal Cord Repair via Regulating Reactive Oxygen Species Microenvironment and Synergizing with Mesenchymal Stem Cells
Author(s) -
Liming Li,
Bing Xiao,
Jiafu Mu,
Yu Zhang,
Chenyang Zhang,
Hongcui Cao,
Rongjun Chen,
Hirak K. Patra,
Bo Yang,
Shiqing Feng,
Yasuhiko Tabata,
Nigel K.H. Slater,
Jianbin Tang,
Youqing Shen,
Jianqing Gao
Publication year - 2019
Publication title -
acs nano
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.554
H-Index - 382
eISSN - 1936-086X
pISSN - 1936-0851
DOI - 10.1021/acsnano.9b07598
Subject(s) - mesenchymal stem cell , stem cell , transplantation , spinal cord injury , neural stem cell , stem cell therapy , spinal cord , regeneration (biology) , reactive oxygen species , microbiology and biotechnology , chemistry , cancer research , medicine , biology , neuroscience , surgery
Spinal cord injury (SCI) is one of the most debilitating injuries, and transplantation of stem cells in a scaffold is a promising strategy for treatment. However, stem cell treatment of SCI has been severely impaired by the increased generation of reactive oxygen species in the lesion microenvironment, which can lead to a high level of stem cell death and dysfunction. Herein, a MnO 2 nanoparticle (NP)-dotted hydrogel is prepared through dispersion of MnO 2 NPs in a PPFLMLLKGSTR peptide modified hyaluronic acid hydrogel. The peptide-modified hydrogel enables the adhesive growth of mesenchymal stem cells (MSCs) and nerve tissue bridging. The MnO 2 NPs alleviate the oxidative environment, thereby effectively improving the viability of MSCs. Transplantation of MSCs in the multifunctional gel generates a significant motor function restoration on a long-span rat spinal cord transection model and induces an in vivo integration as well as neural differentiation of the implanted MSCs, leading to a highly efficient regeneration of central nervous spinal cord tissue. Therefore, the MnO 2 NP-dotted hydrogel represents a promising strategy for stem-cell-based therapies of central nervous system diseases through the comprehensive regulation of pathological microenvironment complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom